Engineered for the demanding clinical standards of the Czech Republic and Central European orthopedic markets.
The Czech Republic represents one of the most sophisticated and highly regulated healthcare markets in Central and Eastern Europe. With a universal healthcare system managed primarily by the VZP (General Health Insurance Company) and other public insurers, the procurement of orthopedic implants is characterized by a strict focus on clinical efficacy, long-term survivorship data, and cost-efficiency.
Like much of the European Union, the Czech Republic is facing a rapidly aging population. According to demographic projections, over 20% of the population is aged 65 or older, a figure expected to rise significantly over the next two decades. This demographic shift, combined with an active lifestyle among seniors and rising obesity rates, has led to an exponential increase in degenerative joint diseases, specifically osteoarthritis. Consequently, the demand for primary and revision Total Hip Replacement (THR) and Total Knee Replacement (TKR) procedures has reached unprecedented levels, placing immense pressure on public and private hospital budgets.
The regulatory landscape in the Czech Republic is governed by the State Institute for Drug Control (SÚKL), which enforces strict alignment with the European Union’s Medical Device Regulation (EU MDR 2017/745). For Class III medical devices, such as total joint prostheses, the compliance threshold is exceptionally high. Manufacturers must provide comprehensive clinical evaluation reports (CER), robust post-market clinical follow-up (PMCF) data, and full traceability of raw materials. HBM Medical’s implants, certified under CE (MDR) and ISO 13485, seamlessly meet these stringent requirements, ensuring smooth registration and procurement processes for Czech distributors and healthcare providers.
Discover the engineering excellence behind our high-survivorship joint replacement systems.
Our femoral stems utilize a vacuum plasma-sprayed Titanium (Ti) and Hydroxyapatite (HA) double coating. This dual-layer technology promotes rapid, stable biological osseointegration, minimizing the risk of aseptic loosening in cementless hip arthroplasty.
For articulating surfaces, we employ premium Cobalt-Chromium-Molybdenum (CoCrMo) alloys. Manufactured via state-of-the-art CNC milling, these components offer ultra-low friction coefficients and exceptional wear resistance, crucial for active patients.
Our liners are fabricated from UHMWPE, subjected to controlled gamma irradiation and thermal treatment. This process significantly reduces free radicals, dramatically lowering long-term wear rates and osteolysis risks.
Established in 2015, HBM Medical Apparatus And Instruments Co., Ltd. has grown into a premier developer and manufacturer of orthopedic implants and surgical instruments. Spanning over 30,000 square meters of advanced manufacturing space, our facility houses 12 automated production lines and more than 120 high-precision machining centers.
Our R&D division is powered by 31 dedicated engineers, including specialists with doctoral and postgraduate degrees in biomaterials and mechanical engineering. With 25 new products launched annually, we maintain a cutting-edge portfolio that aligns with the rapid evolution of global orthopedic surgery.
For the Czech market, we offer comprehensive OEM/ODM and customized manufacturing services, allowing local distributors to tailor implant geometries and instrument configurations to the specific preferences of regional clinical centers in Prague, Brno, and Ostrava.
Partner With Us
Efficiency in the operating theater is paramount for managing the high volume of arthroplasty procedures in Czech public hospitals. HBM Medical does not merely supply implants; we deliver comprehensive surgical solutions designed to streamline workflows, reduce anesthesia times, and minimize intraoperative complications.
Our surgical instrument kits, such as the PGR System and Acetabular Reamer sets, are engineered with high-grade stainless steel and lightweight aluminum alloys. Designed in collaboration with practicing orthopedic surgeons, these instruments offer intuitive, sequential layouts that match the standard surgical steps for both posterior and anterior approaches to the hip, as well as medial parapatellar approaches to the knee.
Czech patients exhibit diverse anatomical profiles. To address this, our THR and TKR portfolios feature highly modular designs. With multiple offset options, neck angles, and proportional sizing for femoral stems and tibial trays, surgeons can achieve precise joint reconstruction, restoring natural biomechanics, leg length, and joint stability without the need for extensive bone resection.
Pioneering the next generation of joint reconstruction technologies to elevate patient outcomes.
We are actively developing trabecular metal structures utilizing advanced additive manufacturing (3D printing). These highly porous scaffolds mimic natural cancellous bone, facilitating rapid bone ingrowth and superior secondary stability for complex revision surgeries.
As robotic arthroplasty gains traction in major Czech clinical centers, our engineering team is integrating digital tracking arrays and optical markers into our instrument systems, ensuring seamless compatibility with leading robotic surgical platforms.
To combat periprosthetic joint infections (PJI)—one of the most devastating complications in arthroplasty—we are researching silver-nanoparticle and antibiotic-eluting coatings designed to prevent biofilm formation on implant surfaces.
Explore our full range of surgical instruments, veterinary systems, and specialized orthopedic implants.
Key insights for procurement officers, distributors, and orthopedic surgeons in the Czech Republic.
Elevate your orthopedic portfolio with EU MDR-compliant, clinically proven joint reconstruction systems. Contact our global business development team today to discuss distribution opportunities, OEM partnerships, or hospital procurement contracts in the Czech Republic.
Send Inquiry Now